Hormonal replacement therapy in surgical menopause with underlying endometriosis

Journal of the Medical Association of Thailand

Volumn 86, Issue 8, 2003, Pages 702-707

  Rattanachaiyanont, Manee ^a   Angsuwatthana, Surasak ^a   Inthawiwat, Suchada ^a   Tanmahasamut, Prasong ^a   Techatraisak, Kitirat ^a   Leerasiri, Pichai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Endometriosis; HRT; Surgical Menopause

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ESTROGEN DEFICIENCY; FEMALE; FOLLOW UP; GYNECOLOGIC SURGERY; HORMONAL THERAPY; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; RECURRENT DISEASE; SALPINGOOOPHORECTOMY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ENDOMETRIOSIS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYSTERECTOMY; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0141702046     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. th ed. Philadelphia: Lippincott Williams & Wilkins; 1999: 1057-73.
2. Corson SL. Surgical treatment of endometriosis-associated pain. In: Corson SL, editor. Endometriosis: The enigmatic disease. 1 ed. Oklahoma: Essential Medical Information System Inc; 1992: 100-9.
3. Hasson HM. Incidence of endometriosis in diagnostic laparoscopy. J Reprod Med 1976; 16: 135-8.
4. Tyson JE. Surgical consideration in gynecological endocrine disorders. Surg Clin North Am 1974; 54: 425-42.
5. Henderson AF, Studd JWW, Watson N. A retrospective study of oestrogen replacement therapy following hysterectomy for the treatment of endometriosis. In: Shaw RW, editor. Advances in reproductive endocrinology. Lancaster: Parthenon; 1990: 131-8.
6. Ranney B. Endometriosis III. Complete operations, reasons, sequelae and treatment. Am J Obstet Gynecol 1971; 109: 1137-44.
7. Gucer F, Pieber D, Arikan MG. Malignancy arising in extraovarian endometriosis during estrogen stimulation. Eur J Gynaecol Oncol 1998; 19: 39-41.
8. Purdie DM, Bain CJ, Siskind V, et al. Hormone replacement therapy and risk of epithelial ovarian cancer. BJC 1999; 81: 559-63.
9. Namnoum AB, Hickman TN, Goodman SB, Gehlbach DL, Rock JA. Incidence of symptom recurrence after hysterectomy for endometriosis. Fertil Steril 1995; 64: 898-902.
10. Hickman TN, Namnoum AB, Hinton EL, Zacur HA, Rock JA. Timing of estrogen replacement therapy following hysterectomy with oophorectomy for endometriosis. Obstet Gynecol 1998; 91: 673-7.
11. Matorras R, Elorriaga MA, Pijoan JI, Ramon O, Rodriguez-Escudero FJ. Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy. Fertil Steril 2002; 77: 303-8.
12. Redwine DB. Endometriosis persisting after castration: Clinical characteristics and results of surgical management. Obstet Gynecol 1994; 83: 405-13.
13. Thom MH. Procedures in practice, hormonal implantation. Br Med J 1980; 280: 648-50.
14. ACOG. ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000; 71: 183-96.
15. ACOG. ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces Technical Bulletin Number 184, September 1993). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000; 71: 183-96.
16. Fedele L, Bianchi S, Raffaelli R, Zanconato G. Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis. Maturitas 1999; 32: 189-93.
17. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990; 75: 1023-8.
18. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002; 288: 49-57.
19. Writing Group for Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.